beta
MYOS
MYOS RENS Technology, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.
Market Cap: 12.3 Million
Primary Exchange: NASDAQ
Website: http://www.myosrens.com
Shares Outstanding: 12.2 Million
Float: 6.52 Million
Dividend: (%)
Beta: 0.6840746755251234
Sector: Health Technology
Industry: Medical Specialties
Ethical Flags
Longest drawdown: 1674 trading days
From: 2014-09-17 To: 2020-11-17
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|